Trial Profile
An Open Label, Randomised, Single Dose, Three-way Crossover Study to Investigate the Relative Bioavailability of a 100mg Capsule Compared to Four 25mg GSK598809 Capsules and the Effect of Food on the Pharmacokinetics of the 100mg Capsule in Healthy Male and Female Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs GSK 598809 (Primary)
- Indications Eating disorders; Smoking withdrawal; Substance-related disorders
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 15 May 2014 New trial record